Further Information
N-terminal kinase-like protein, Coated vesicle-associated kinase of 90 kDa, SCY1-like protein 1, Telomerase regulation-associated protein, Telomerase transcriptional element-interacting factor, Teratoma-associated tyrosine kinase, SCYL1, CVAK90, GKLP, NTKL, TAPK, TEIF, TRAP
For WB starting dilution is: 1:1000
For IHC-P starting dilution is: 1:10~50
SCYL1 forms multimers following transfection into COS-7 cells. SCYL1 forms a 300-kD trimer using crosslinking reagents. Biochemical analysis revealed no phosphorylation or autophosphorylation activity.The 707-amino acid SCYL1 variant, variant 2, localized to centrosomes during mitosis. During interphase, fluorescence-tagged variant 2 localized in the cytoplasm as well as centrosomes. However, at the beginning of mitosis, the fluorescence appeared as a pair of bright nuclear foci that followed centrosome localization throughout mitosis, while maintaining diffuse cytoplasmic labeling. Endogenous variant 2 in HeLa cells showed a similar staining pattern. Centrosomal localization was independent of microtubules.
- Tang, Z., et al., Biochem. Biophys. Res. Commun. 324(4):1324-1332 (2004).
- Kato, M., et al., Genomics 79(6):760-767 (2002).
- Liu, S.C., et al., Biochim. Biophys. Acta 1517(1):148-152 (2000).
- van Asseldonk, M., et al., Genomics 66(1):35-42 (2000).
Supplied in PBS with 0.09% (W/V) sodium azide.
batch dependent
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Predicted species reactivity based on immunogen sequence: Bovine
This SCYL1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 156-185 amino acids from the N-terminal region of human SCYL1.
57410
N-terminal kinase-like protein
SCYL1
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
90 kDa
Q96KG9
74762671
This antibody is purified through a protein A column, followed by peptide affinity purification.
Neuroscience,Signal Transduction
Q96KG9
Optimal dilutions for each application to be determined by the researcher.